Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Polypharmacy prevalence rates in the treatment of unipolar depression in an outpatient clinic.

Glezer A, Byatt N, Cook R Jr, Rothschild AJ.

J Affect Disord. 2009 Sep;117(1-2):18-23. doi: 10.1016/j.jad.2008.11.016. Epub 2008 Dec 21.

PMID:
19103462
2.

National trends in psychotropic medication polypharmacy in office-based psychiatry.

Mojtabai R, Olfson M.

Arch Gen Psychiatry. 2010 Jan;67(1):26-36. doi: 10.1001/archgenpsychiatry.2009.175.

PMID:
20048220
5.

Conventional antipsychotic prescription in unipolar depression, II: withdrawing conventional antipsychotics in unipolar, nonpsychotic patients.

Mortimer AM, Martin M, Wheeler Vega JA, Tyson PJ.

J Clin Psychiatry. 2003 Jun;64(6):668-72; quiz 738-9.

PMID:
12823081
6.
7.

Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.

Malhi GS, Ng F, Berk M.

Aust N Z J Psychiatry. 2008 Apr;42(4):346-9. doi: 10.1080/00048670701881587.

PMID:
18330778
8.

[Antidepressants consumption in the global population in France].

Olié JP, Elomari F, Spadone C, Lépine JP.

Encephale. 2002 Sep-Oct;28(5 Pt 1):411-7. French.

PMID:
12386542
9.

Nonsomatic treatment of depression.

Sherrill JT, Kovacs M.

Child Adolesc Psychiatr Clin N Am. 2002 Jul;11(3):579-93. Review.

PMID:
12222084
10.

Cognitive therapy vs medications in the treatment of moderate to severe depression.

DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, O'Reardon JP, Lovett ML, Gladis MM, Brown LL, Gallop R.

Arch Gen Psychiatry. 2005 Apr;62(4):409-16.

PMID:
15809408
11.
12.

Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).

Vieta E, Herraiz M, Fernández A, Gastó C, Benabarre A, Colom F, Martínez-Arán A, Reinares M.

J Clin Psychiatry. 2001 Aug;62(8):623-30.

PMID:
11561935
13.

The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.

Alexopoulos GS, Katz IR, Reynolds CF 3rd, Carpenter D, Docherty JP; Expert Consensus Panel for Pharmacotherapy of Depressive Disorders in Older Patients.

Postgrad Med. 2001 Oct;Spec No Pharmacotherapy:1-86.

PMID:
17205639
14.

Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.

Sonawalla SB, Spillmann MK, Kolsky AR, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M.

J Clin Psychiatry. 1999 Sep;60(9):580-3.

PMID:
10520975
15.

A description of next-step switching versus augmentation practices for outpatients with treatment-resistant major depressive disorder enrolled in an academic specialty clinic.

Papakostas GI, Petersen TJ, Green C, Iosifescu DV, Yeung AS, Nierenberg AA, Fava M, Posternak MA.

Ann Clin Psychiatry. 2005 Jul-Sep;17(3):161-5.

PMID:
16433058
16.

The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?

Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM.

J Clin Psychiatry. 2004 Apr;65(4):521-30.

PMID:
15119915
17.

Improving treatment of late life depression in primary care: a randomized clinical trial.

Callahan CM, Hendrie HC, Dittus RS, Brater DC, Hui SL, Tierney WM.

J Am Geriatr Soc. 1994 Aug;42(8):839-46.

PMID:
8046193
18.

Bupropion in tricyclic antidepressant nonresponders with unipolar major depressive disorder.

Ferguson J, Cunningham L, Merideth C, Apter J, Feighner J, Ionescu-Pioggia M, Samara B, Johnston JA, Ascher J.

Ann Clin Psychiatry. 1994 Sep;6(3):153-60.

PMID:
7881495
19.

Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.

Schmidt PJ, Daly RC, Bloch M, Smith MJ, Danaceau MA, St Clair LS, Murphy JH, Haq N, Rubinow DR.

Arch Gen Psychiatry. 2005 Feb;62(2):154-62.

PMID:
15699292

Supplemental Content

Support Center